Header Logo

Connection

Douglas Corley to Risk Factors

Back to Details
This is a "connection" page, showing publications Douglas Corley has written about Risk Factors.
Douglas Corley
Connection Strength
3.706
Risk Factors
  1. Rising Early-onset Colorectal Cancer Incidence Is Not an Artifact of Increased Screening Colonoscopy Use in a Large, Diverse Healthcare System. Gastroenterology. 2022 01; 162(1):325-327.e3.
    View in: PubMed
    Score: 0.118
  2. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. Am J Gastroenterol. 2021 05 01; 116(5):949-957.
    View in: PubMed
    Score: 0.115
  3. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
    View in: PubMed
    Score: 0.109
  4. Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population. Am J Gastroenterol. 2020 05; 115(5):706-715.
    View in: PubMed
    Score: 0.108
  5. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
    View in: PubMed
    Score: 0.103
  6. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 2019 01; 156(1):63-74.e6.
    View in: PubMed
    Score: 0.096
  7. When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. Gastroenterology. 2018 10; 155(4):947-949.
    View in: PubMed
    Score: 0.096
  8. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc. 2019 01; 89(1):168-176.e3.
    View in: PubMed
    Score: 0.096
  9. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastrointest Endosc Clin N Am. 2017 Jul; 27(3):353-364.
    View in: PubMed
    Score: 0.088
  10. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641.
    View in: PubMed
    Score: 0.087
  11. Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors. J Cancer Surviv. 2017 Jun; 11(3):393-400.
    View in: PubMed
    Score: 0.086
  12. Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut. 2018 03; 67(3):418-529.
    View in: PubMed
    Score: 0.085
  13. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus. Dig Dis Sci. 2016 Jan; 61(1):70-9.
    View in: PubMed
    Score: 0.078
  14. Food, the immune system, and the gastrointestinal tract. Gastroenterology. 2015 May; 148(6):1083-6.
    View in: PubMed
    Score: 0.076
  15. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol. 2015 Feb; 29(1):29-39.
    View in: PubMed
    Score: 0.074
  16. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus. Dig Dis Sci. 2015 Feb; 60(2):436-43.
    View in: PubMed
    Score: 0.073
  17. Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol. 2014 Oct; 109(10):1586-94.
    View in: PubMed
    Score: 0.072
  18. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014 Jun 17; 160(12):828-35.
    View in: PubMed
    Score: 0.072
  19. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut. 2013 Dec; 62(12):1684-91.
    View in: PubMed
    Score: 0.065
  20. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):172-80.
    View in: PubMed
    Score: 0.063
  21. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012 Apr; 142(4):744-53.
    View in: PubMed
    Score: 0.061
  22. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel. J Natl Cancer Inst. 2011 Jul 06; 103(13):994-5.
    View in: PubMed
    Score: 0.058
  23. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101.
    View in: PubMed
    Score: 0.053
  24. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr Cancer. 2009; 61(5):607-16.
    View in: PubMed
    Score: 0.049
  25. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15.
    View in: PubMed
    Score: 0.049
  26. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11.
    View in: PubMed
    Score: 0.048
  27. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.048
  28. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol. 2008 Jul; 103(7):1614-23; quiz 1624.
    View in: PubMed
    Score: 0.047
  29. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.047
  30. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):352-8.
    View in: PubMed
    Score: 0.046
  31. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46.
    View in: PubMed
    Score: 0.046
  32. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007 Oct; 133(4):1106-12.
    View in: PubMed
    Score: 0.044
  33. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.044
  34. Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus. Am J Hum Genet. 2016 08 04; 99(2):352-65.
    View in: PubMed
    Score: 0.042
  35. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.041
  36. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):872-8.
    View in: PubMed
    Score: 0.041
  37. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations. Nat Commun. 2023 10 02; 14(1):6147.
    View in: PubMed
    Score: 0.034
  38. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
    View in: PubMed
    Score: 0.032
  39. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.029
  40. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis. 2021 04 17; 42(3):369-377.
    View in: PubMed
    Score: 0.029
  41. Response to Li and Hopper. Am J Hum Genet. 2021 03 04; 108(3):527-529.
    View in: PubMed
    Score: 0.029
  42. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
    View in: PubMed
    Score: 0.028
  43. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
    View in: PubMed
    Score: 0.028
  44. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2020 12; 159(6):2065-2076.e1.
    View in: PubMed
    Score: 0.028
  45. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.028
  46. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. Am J Hum Genet. 2020 09 03; 107(3):432-444.
    View in: PubMed
    Score: 0.027
  47. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
    View in: PubMed
    Score: 0.027
  48. Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer. Gastroenterology. 2020 04; 158(5):1274-1286.e12.
    View in: PubMed
    Score: 0.026
  49. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. Cancer Causes Control. 2020 Jan; 31(1):85-93.
    View in: PubMed
    Score: 0.026
  50. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol. 2020 11; 18(12):2701-2709.e3.
    View in: PubMed
    Score: 0.026
  51. Morbidity and Mortality After Surgery for Nonmalignant Colorectal Polyps: A 10-Year Nationwide Analysis. Am J Gastroenterol. 2019 11; 114(11):1802-1810.
    View in: PubMed
    Score: 0.026
  52. Incidence rates of cardiovascular outcomes in a community-based population of cancer patients. Cancer Med. 2019 12; 8(18):7913-7923.
    View in: PubMed
    Score: 0.026
  53. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
    View in: PubMed
    Score: 0.026
  54. World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. Gastroenterology. 2018 09; 155(3):909-925.e3.
    View in: PubMed
    Score: 0.024
  55. Early indicators of prognosis in upper gastrointestinal hemorrhage. Am J Gastroenterol. 1998 Mar; 93(3):336-40.
    View in: PubMed
    Score: 0.023
  56. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology. 2018 04; 154(5):1273-1281.e3.
    View in: PubMed
    Score: 0.023
  57. Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis. Eur J Epidemiol. 2017 11; 32(11):1007-1017.
    View in: PubMed
    Score: 0.022
  58. Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore). 2017 Mar; 96(11):e6326.
    View in: PubMed
    Score: 0.022
  59. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018 02; 67(2):291-298.
    View in: PubMed
    Score: 0.021
  60. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017 10; 66(10):1739-1747.
    View in: PubMed
    Score: 0.021
  61. Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int. 2016 12; 27(12):3477-3484.
    View in: PubMed
    Score: 0.021
  62. Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int. 2006; 17(6):922-8.
    View in: PubMed
    Score: 0.020
  63. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
    View in: PubMed
    Score: 0.020
  64. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016 Apr; 85:142-7.
    View in: PubMed
    Score: 0.020
  65. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One. 2015; 10(10):e0140180.
    View in: PubMed
    Score: 0.020
  66. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1739-47.
    View in: PubMed
    Score: 0.020
  67. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1692-8.
    View in: PubMed
    Score: 0.020
  68. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1801-3.
    View in: PubMed
    Score: 0.020
  69. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One. 2015; 10(6):e0128617.
    View in: PubMed
    Score: 0.019
  70. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 May; 110(5):662-82; quiz 683.
    View in: PubMed
    Score: 0.019
  71. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology. 2015 Jun; 148(7):1353-61.e3.
    View in: PubMed
    Score: 0.019
  72. Diet and upper gastrointestinal malignancies. Gastroenterology. 2015 May; 148(6):1234-1243.e4.
    View in: PubMed
    Score: 0.019
  73. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.019
  74. Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology. 2015 Jan; 26(1):59-67.
    View in: PubMed
    Score: 0.019
  75. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec; 35(12):2740-7.
    View in: PubMed
    Score: 0.018
  76. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014 Nov; 106(11).
    View in: PubMed
    Score: 0.018
  77. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One. 2014; 9(7):e103508.
    View in: PubMed
    Score: 0.018
  78. Approaches for classifying the indications for colonoscopy using detailed clinical data. BMC Cancer. 2014 Feb 15; 14:95.
    View in: PubMed
    Score: 0.017
  79. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol. 2014 Oct; 12(10):1667-76.e1.
    View in: PubMed
    Score: 0.017
  80. Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis. J Gastroenterol. 2014 Jun; 49(6):992-1000.
    View in: PubMed
    Score: 0.017
  81. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013 Nov 20; 105(22):1711-8.
    View in: PubMed
    Score: 0.017
  82. Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. Nutr Rev. 2013 Jul; 71(7):474-82.
    View in: PubMed
    Score: 0.017
  83. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013 May; 37(10):953-62.
    View in: PubMed
    Score: 0.016
  84. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.016
  85. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol. 2012 Jun; 36(3):306-16.
    View in: PubMed
    Score: 0.015
  86. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3.
    View in: PubMed
    Score: 0.015
  87. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. 2011 Aug; 60(8):1029-37.
    View in: PubMed
    Score: 0.014
  88. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010 Sep 08; 102(17):1344-53.
    View in: PubMed
    Score: 0.014
  89. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev. 2010 Dec; 23(2):230-46.
    View in: PubMed
    Score: 0.014
  90. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010 Jul; 46(11):2067-76.
    View in: PubMed
    Score: 0.013
  91. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1366-72; quiz 1301.
    View in: PubMed
    Score: 0.010
  92. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis. 2005 Mar 01; 191(5):761-7.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente